R & D Focus: New report shows nearly 600 medicines in development for pediatric patients

America ’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and adolescents can be complex and often require different clinical approaches than adult treatment pathways. Acc ording to anew reportreleased today, there are nearly 600 pediatric medicines currently in development.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Drug Development Clinical Trials New Era of Medicine & D Focus Pediatrics Source Type: news